Cargando…
Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review
INTRODUCTION: Neuropsychiatric symptoms are an integral component of the natural history of dementia, occurring from prodromal to advanced stages of the disease process and causing increased burden and morbidity. Clinical presentations are pleomorphic and clinical management often requires combinati...
Autores principales: | Stella, Florindo, Valiengo, Leandro C. Lane, de Paula, Vanessa J. R., Lima, Carlos Augusto de Mendonça, Forlenza, Orestes V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação de Psiquiatria do Rio Grande do Sul
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835388/ https://www.ncbi.nlm.nih.gov/pubmed/34374269 http://dx.doi.org/10.47626/2237-6089-2021-0288 |
Ejemplares similares
-
Mood disorders in the elderly: prevalence, functional impact, and management challenges
por: Valiengo, Leandro da Costa Lane, et al.
Publicado: (2016) -
Assessment of neuropsychiatric symptoms in dementia: toward improving
accuracy
por: Stella, Florindo
Publicado: (2013) -
Electroconvulsive therapy for treating patients with agitation and related behavioral disorders due to dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2023) -
Impact of SARS-CoV-2 pandemic on mental health in the elderly: perspective from a psychogeriatric clinic at a tertiary hospital in São Paulo, Brazil
por: Forlenza, Orestes V., et al.
Publicado: (2020) -
Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review
por: Hillen, Jodie Belinda, et al.
Publicado: (2019)